BioMed Realty Announces Illumina, Inc., As Sole Tenant For San Diego i3 Campus

SAN DIEGO, April 5, 2016 /PRNewswire/ -- BioMed Realty today announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics focused on improving human health by unlocking the power of the genome, has signed a 10 year lease at BioMed Realty's i3 campus, a 316,000 square foot development currently under construction in the University Towne Centre (UTC) life science market of San Diego. i3 will serve as expansion of Illumina's headquarters, with move-in expected in July 2017.

The i3 lease agreement marks the third major lease for new construction that BioMed Realty and Illumina have completed within the last 15 months. Following completed build-to-suit lease agreements for 360,000 square feet at Lincoln Centre in Foster City, California, in, December 2014 and 155,000 square feet at Granta Park in Cambridge, U.K., in June 2015, the i3 lease brings BioMed Realty to a total of 831,000 square feet of premier laboratory and office space leased to Illumina in California and the U.K. in less than a year and a half. 

"Expanding to i3 enables us to continue our growth in San Diego, our home city and a source of top talent in our industry," said Marc Stapley, Executive Vice President, Chief Administrative Officer and Chief Financial Officer at Illumina. "i3 creates a near-term opportunity for us to accommodate our growing teams in a location very close to our headquarters, where we expect to reach full occupancy in the next year."

"We are thrilled to welcome Illumina to our i3 campus," said Alan D. Gold, Chief Executive Officer of BioMed Realty. "Illumina's unmatched success and reputation as a global leader in genomics is the perfect fit for this iconic campus, which will bring together the key elements needed for their employees to thrive – flexible design, great amenities and easy access to transportation. We look forward to supporting Illumina's growth in San Diego as part of our continued and expanded relationship."

Creating an atmosphere of connectivity, innovation and collaboration, the i3 campus will be comprised of three 100,000 square foot customizable buildings. The campus will include a variety of indoor and outdoor amenities, fuel cell energy generation, and operable windows. With these elements, i3 is being built not only to meet, but to surpass the requirements for LEED Platinum certification. The campus core and shell construction is expected to be completed in July 2016.

In addition to i3, BioMed Realty's UTC portfolio includes its Axiom campus, formerly known as Towne Centre Technology Park, which BioMed Realty purchased in 2015 and is redeveloping, and the adjacent UTC Campus @ Towne Centre, which BioMed Realty acquired in April 2016.

For more information about i3 and BioMed Realty's portfolio across the U.S. and U.K., please visit biomedrealty.com. 

About BioMed Realty
BioMed Realty invests in the highest quality institutional real estate to meet the needs of the growing demand across the life science industry. The company owns or has interests in properties comprising approximately 19.1 million rentable square feet. Additional information is available at www.biomedrealty.com. Follow us on Twitter @biomedrealty.

SOURCE BioMed Realty

Related Links

http://www.biomedrealty.com